207 related articles for article (PubMed ID: 31685801)
21. RBBP6 increases radioresistance and serves as a therapeutic target for preoperative radiotherapy in colorectal cancer.
Xiao C; Wang Y; Zheng M; Chen J; Song G; Zhou Z; Zhou C; Sun X; Zhong L; Ding E; Zhang Y; Yang L; Wu G; Xu S; Zhang H; Wang X
Cancer Sci; 2018 Apr; 109(4):1075-1087. PubMed ID: 29369481
[TBL] [Abstract][Full Text] [Related]
22. TRAF6 inhibits colorectal cancer metastasis through regulating selective autophagic CTNNB1/β-catenin degradation and is targeted for GSK3B/GSK3β-mediated phosphorylation and degradation.
Wu H; Lu XX; Wang JR; Yang TY; Li XM; He XS; Li Y; Ye WL; Wu Y; Gan WJ; Guo PD; Li JM
Autophagy; 2019 Sep; 15(9):1506-1522. PubMed ID: 30806153
[TBL] [Abstract][Full Text] [Related]
23. CBP mediated DOT1L acetylation confers DOT1L stability and promotes cancer metastasis.
Liu C; Yang Q; Zhu Q; Lu X; Li M; Hou T; Li Z; Tang M; Li Y; Wang H; Yang Y; Wang H; Zhao Y; Wen H; Liu X; Mao Z; Zhu WG
Theranostics; 2020; 10(4):1758-1776. PubMed ID: 32042335
[No Abstract] [Full Text] [Related]
24. Oncogene FOXK1 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition.
Wu Y; Peng Y; Wu M; Zhang W; Zhang M; Xie R; Zhang P; Bai Y; Zhao J; Li A; Nan Q; Chen Y; Ren Y; Liu S; Wang J
Oncotarget; 2016 Aug; 7(32):51150-51162. PubMed ID: 27223064
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-302c represses epithelial-mesenchymal transition and metastasis by targeting transcription factor AP-4 in colorectal cancer.
Ma W; Liu B; Li J; Jiang J; Zhou R; Huang L; Li X; He X; Zhou Q
Biomed Pharmacother; 2018 Sep; 105():670-676. PubMed ID: 29906744
[TBL] [Abstract][Full Text] [Related]
26. Phosphorylation of BCKDK of BCAA catabolism at Y246 by Src promotes metastasis of colorectal cancer.
Tian Q; Yuan P; Quan C; Li M; Xiao J; Zhang L; Lu H; Ma T; Zou L; Wang F; Xue P; Ni X; Wang W; Liu L; Wang Z; Zhu F; Duan Q
Oncogene; 2020 May; 39(20):3980-3996. PubMed ID: 32238881
[TBL] [Abstract][Full Text] [Related]
27. RNF43 ubiquitinates and degrades phosphorylated E-cadherin by c-Src to facilitate epithelial-mesenchymal transition in lung adenocarcinoma.
Zhang Y; Sun L; Gao X; Guo A; Diao Y; Zhao Y
BMC Cancer; 2019 Jul; 19(1):670. PubMed ID: 31286874
[TBL] [Abstract][Full Text] [Related]
28. Expression Analysis of RbBP6 in human cancers: a Prospective biomarker.
Mbita Z; Hull R; Mbele M; Makhafola T; Dlamini Z
Anticancer Drugs; 2019 Sep; 30(8):767-773. PubMed ID: 31274515
[TBL] [Abstract][Full Text] [Related]
29. Loss of vinculin and membrane-bound β-catenin promotes metastasis and predicts poor prognosis in colorectal cancer.
Li T; Guo H; Song Y; Zhao X; Shi Y; Lu Y; Hu S; Nie Y; Fan D; Wu K
Mol Cancer; 2014 Dec; 13():263. PubMed ID: 25496021
[TBL] [Abstract][Full Text] [Related]
30. Gab2 facilitates epithelial-to-mesenchymal transition via the MEK/ERK/MMP signaling in colorectal cancer.
Ding C; Luo J; Li L; Li S; Yang L; Pan H; Liu Q; Qin H; Chen C; Feng J
J Exp Clin Cancer Res; 2016 Jan; 35():5. PubMed ID: 26754532
[TBL] [Abstract][Full Text] [Related]
31. Defining UHRF1 Domains that Support Maintenance of Human Colon Cancer DNA Methylation and Oncogenic Properties.
Kong X; Chen J; Xie W; Brown SM; Cai Y; Wu K; Fan D; Nie Y; Yegnasubramanian S; Tiedemann RL; Tao Y; Chiu Yen RW; Topper MJ; Zahnow CA; Easwaran H; Rothbart SB; Xia L; Baylin SB
Cancer Cell; 2019 Apr; 35(4):633-648.e7. PubMed ID: 30956060
[TBL] [Abstract][Full Text] [Related]
32. The E3 ubiquitin ligase RNF146 promotes colorectal cancer by activating the Wnt/β-catenin pathway via ubiquitination of Axin1.
Shen J; Yu Z; Li N
Biochem Biophys Res Commun; 2018 Sep; 503(2):991-997. PubMed ID: 29932918
[TBL] [Abstract][Full Text] [Related]
33. Snail/FOXK1/Cyr61 Signaling Axis Regulates the Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.
Huang X; Xiang L; Li Y; Zhao Y; Zhu H; Xiao Y; Liu M; Wu X; Wang Z; Jiang P; Qing H; Zhang Q; Liu G; Zhang W; Li A; Chen Y; Liu S; Wang J
Cell Physiol Biochem; 2018; 47(2):590-603. PubMed ID: 29794466
[TBL] [Abstract][Full Text] [Related]
34. microRNA-219-5p inhibits epithelial-mesenchymal transition and metastasis of colorectal cancer by targeting lymphoid enhancer-binding factor 1.
Huang LX; Hu CY; Jing L; Wang MC; Xu M; Wang J; Wang Y; Nan KJ; Wang SH
Cancer Sci; 2017 Oct; 108(10):1985-1995. PubMed ID: 28771881
[TBL] [Abstract][Full Text] [Related]
35. RING-Finger Protein 6 Amplification Activates JAK/STAT3 Pathway by Modifying SHP-1 Ubiquitylation and Associates with Poor Outcome in Colorectal Cancer.
Liang Q; Ma D; Zhu X; Wang Z; Sun TT; Shen C; Yan T; Tian X; Yu T; Guo F; Tang J; Lin Y; Chen H; Zhou C; Ge Z; Zhong M; Chen J; Liu Q; Wang Z; Fang JY; Chen H; Hong J
Clin Cancer Res; 2018 Mar; 24(6):1473-1485. PubMed ID: 29288235
[No Abstract] [Full Text] [Related]
36. RHBDD1 promotes colorectal cancer metastasis through the Wnt signaling pathway and its downstream target ZEB1.
Zhang M; Miao F; Huang R; Liu W; Zhao Y; Jiao T; Lu Y; Wu F; Wang X; Wang H; Zhao H; Ju H; Miao S; Wang L; Song W
J Exp Clin Cancer Res; 2018 Feb; 37(1):22. PubMed ID: 29426364
[TBL] [Abstract][Full Text] [Related]
37. Karyopherin β1 deletion suppresses tumor growth and metastasis in colorectal cancer (CRC) by reducing MET expression.
Zhang Y; Li KF
Biomed Pharmacother; 2019 Dec; 120():109127. PubMed ID: 31629952
[TBL] [Abstract][Full Text] [Related]
38. DcR3 induces epithelial-mesenchymal transition through activation of the TGF-β3/SMAD signaling pathway in CRC.
Liu YP; Zhu HF; Liu DL; Hu ZY; Li SN; Kan HP; Wang XY; Li ZG
Oncotarget; 2016 Nov; 7(47):77306-77318. PubMed ID: 27764793
[TBL] [Abstract][Full Text] [Related]
39. RNF6 facilitates metastasis and radioresistance in hepatocellular carcinoma through ubiquitination of FoxA1.
Cai J; Xiong Q; Jiang X; Zhou S; Liu T
Exp Cell Res; 2019 Jan; 374(1):152-161. PubMed ID: 30496760
[TBL] [Abstract][Full Text] [Related]
40. STIM1, a direct target of microRNA-185, promotes tumor metastasis and is associated with poor prognosis in colorectal cancer.
Zhang Z; Liu X; Feng B; Liu N; Wu Q; Han Y; Nie Y; Wu K; Shi Y; Fan D
Oncogene; 2015 Sep; 34(37):4808-20. PubMed ID: 25531324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
